Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Colorectal Neoplasm Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04160416
What this trial is testing

MXELOXIRI Combined With Molecular Targeted Drug in mCRC

Who this might be right for
Unresectable Metastatic Colorectal Cancer
First Affiliated Hospital of Zhejiang University 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07007728
What this trial is testing

Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver Metastasis

Who this might be right for
Colorectal NeoplasmsSecondary Malignant Neoplasm of Liver
Peking University Cancer Hospital & Institute 54
Testing effectiveness (Phase 2)UnknownNCT00075595
What this trial is testing

Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Looking for participantsNCT07257653
What this trial is testing

The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsRASBRAF+2 more
Zhejiang University 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT05736731
What this trial is testing

Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultSolid TumorPancreatic Cancer+13 more
A2 Biotherapeutics Inc. 160
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Post-approval studies (Phase 4)Study completedNCT01972490
What this trial is testing

Avastin in Combination With Chemotherapy for RAS Mutant Unresectable Colorectal Liver-limited Metastases

Who this might be right for
Colorectal Neoplasms
Xu jianmin 241
Testing effectiveness (Phase 2)Study completedNCT00002997
What this trial is testing

Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)UnknownNCT05068206
What this trial is testing

A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx

Who this might be right for
Unresectable Metastatic Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT00041652
What this trial is testing

Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer

Who this might be right for
Colorectal CancerColon CancerRectal Cancer+4 more
Gilead Sciences 30
Testing effectiveness (Phase 2)UnknownNCT06148402
What this trial is testing

Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable/Metastatic Colorectal Cancer

Who this might be right for
Unresectable/Metastatic Colorectal Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07750041
What this trial is testing

A Phase Ib/II Study of SYS6090 Combination Therapy in Advanced Colorectal Cancer

Who this might be right for
Unresectable Advanced or Metastatic Colorectal Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd. 260
Early research (Phase 1)Study completedNCT00004095
What this trial is testing

Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+3 more
Northwestern University 38
Early research (Phase 1)Temporarily pausedNCT05400122
What this trial is testing

Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer

Who this might be right for
Colorectal CancerHematologic MalignancyRectum Cancer+15 more
David Wald 12
Not applicableNot Yet RecruitingNCT07811453
What this trial is testing

Liver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatment Options

Who this might be right for
Colorectal NeoplasmsLiver NeoplasmsNeoplasm Metastases+2 more
Charite University, Berlin, Germany 260
Testing effectiveness (Phase 2)WithdrawnNCT00388700
What this trial is testing

A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Galectin Therapeutics Inc.
Not applicableLooking for participantsNCT05967143
What this trial is testing

Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)Liver Metastases From Colorectal Cancer (mCRC)
Sirtex Medical 845
Testing effectiveness (Phase 2)Ended earlyNCT00043004
What this trial is testing

Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 119
Testing effectiveness (Phase 2)Study completedNCT04513951
What this trial is testing

AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 62
Testing effectiveness (Phase 2)Looking for participantsNCT06937177
What this trial is testing

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

Who this might be right for
Cancer Weight Loss
Endevica Bio 120
Next Page